Novostia is a privately held medical device company developing an innovative artificial heart valve, designed for patients of any age, including children. Novostia endeavors to advance its technology to clinical trials and regulatory approvals to improve the quality of life of millions of people worldwide suffering from aortic and mitral valve disease. For more information please visite www.novostia.com
| Website | http://www.novostia.com |
| Employees | 8 (6 on RocketReach) |
| Founded | 2017 |
| Technologies |
JavaScript
,
HTML
,
Google Analytics
+11 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Medical Device, Health Care |
| Keywords | Heart Valve Replacement, Pediatric Cardiology, Cardiac Surgery, Children's Heart Surgery, Innovative Medical Technology, Minimally Invasive Cardiac Surgery, Heart Valve Technology, Medical Device Development, Clinical Trials, Regulatory Approvals, Biomedical Engineering, Cardiovascular Disease, Heart Disease Treatment, Surgical Devices, Health Technology, Medical Innovation, Healthcare Technology, Advanced Medical Technology |
| Competitors | Johnson & Johnson, Medtronic, Abbott, Stryker, Boston Scientific, Baxter International Inc., Zimmer Biomet, Smith+Nephew, Terumo, Halyard Health +38 more (view full list) |
Looking for a particular Novostia employee's phone or email?
Soad Ghazouani is the CEO of Novostia.
6 people are employed at Novostia.